Mr Mrs Miss Ms Dr Other

Dr
Nienke
Lubben

Partner & Patent Attorney

York Office The Hague Office

Life sciences

Telephone. +44(0) 1904 732 120
Mobile. +44(0) 777 265 2294
Email. nlubben@hgf.com
UPC Representative
Our team of specialist European patent litigators, oppositions specialists and patent attorneys bring together an extensive depth of legal and technical knowledge and are qualified to represent you in the UPC.
Vcard

Experience

Nienke is a European and UK Patent Attorney. Her client base includes several universities, start-ups, independent research institutes and small to medium enterprises. She advises on IP portfolio management and strategy, drafting, patent prosecution, freedom to operate and due diligence relating to potential asset licencing, acquisition or investment. Her extensive experience in drafting and analysing the value of third party patents and patent applications has given her a good understanding of how to prepare patent applications that are attractive to potential investors and licensees. In terms of technologies, Nienke specialises in the field of cell and gene therapy, with particular experience in TCR and CAR-T cell therapies. She has experience in a diverse range of technical subject matter including antibody and peptide therapeutics, viral vector production, biomarkers and diagnostic methods. She has a PhD in cell biology and immunology.

Specialisms

Industries

Services

Qualifications

Patent Attorney

Chartered (UK)
Europe

BSC

Biological Sciences (genetics)

PHD

Cell Biology and Immunology

Recognition

MIP IP Rising Star 2019/20

View recognition online

Download recognition PDF

MIP IP Rising Star 2018/19

View recognition online

Download recognition PDF

Publications

Managing Intellectual Property firm rankings - IP Stars 2024

View publication online

MIP IP Rising Stars 2019/20

View publication online

Related News

Office Closed Dates December 2025 / January 2026

HGF Office Closed Dates December 2025 / January 2026   UK Thursday 25 and Friday 26 December 2025 CLOSED Thursday 1 January 2026* CLOSED * Friday 2 January 2026 – …

Read article

PRESS RELEASE – HGF strengthens European presence with three new Partners in France and Germany

HGF is pleased to announce the arrival of three new partners, further strengthening its European presence. Two partners will be joining the firm’s fast-growing French practice, and one will join …

Read article

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

The Antibody Series #4 | pH points in antibody claims: when “same pH ” becomes an addition of matter

The Boards of Appeal of the EPO (BoA) are the appeal body that reviews EPO decisions; in this case, they reviewed a revocation in opposition of a patent relating to …

Read article

Agritech Thymes: Unlocking the Soil Microbiome: Driving Agritech Innovation in the UK

The UK offers an ideal platform for harnessing the untapped potential of soil and plant microorganisms. Although much of my professional experience has focused on the human microbiome, I have …

Read article

The Antibody Series #1 | Quality Characteristics (CQAs) in Antibody Claims: When the Test Method Can Remain Outside the Claim

Introduction Therapeutic antibodies are at the heart of innovations in biotechnology and healthcare. With increasing regulatory requirements and quality expectations, critical quality attributes (CQAs) are becoming essential in the drafting …

Read article
Event - 3rd February 2026

HGF Brand & Design Conference 2026

Join us on 3rd February 2026 for HGF’s Brand & Design Conference, the must attend event for in-house legal teams, brand leaders, creatives, and innovators shaping the future of IP. …

Event details
See all updates

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.

Contact us